Effect of BDNF Val66Met polymorphism on regional white matter hyperintensities and cognitive function in elderly males without dementia

Psychoneuroendocrinology

Volumn 39, Issue 1, 2014, Pages 94-103

  Huang, Chu Chung ^a   Liu, Mu En ^b   Chou, Kun Hsien ^a   Yang, Albert C ^a,c,d   Hung, Chia Chun ^a,e   Hong, Chen Jee ^a,c   Tsai, Shih Jen ^a,c   Lin, Ching Po ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Aged; Brain derived neurotrophic receptor; Cognition; Polymorphism; White matter hyperintensities

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN SIZE; COGNITION; DEMENTIA; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; LIMBIC CORTEX; MALE; MENTAL PERFORMANCE; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PRIORITY JOURNAL; SHORT TERM MEMORY; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL LOBE; WHITE MATTER LESION; BDNF GENE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENOTYPING TECHNIQUE; IMAGE ANALYSIS; LONG TERM MEMORY; NEUROPATHOLOGY; SUBCORTEX; VERY ELDERLY;

AGED; BRAIN-DERIVED NEUROTROPHIC RECEPTOR; COGNITION; POLYMORPHISM; WHITE MATTER HYPERINTENSITIES;

AGED; AGED, 80 AND OVER; AGING; ALLELES; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84888020120     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.09.027     Document Type: Article

References (55)

1. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51:1173-1182.
2. Baslow M.H., Hrabe J., Guilfoyle D.N. Dynamic relationship between neurostimulation and N-acetylaspartate metabolism in the human visual cortex: evidence that NAA functions as a molecular water pump during visual stimulation. J. Mol. Neurosci. 2007, 32:235-245.
3. Brun A., Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 1986, 19:253-262.
4. Capizzano A.A., Schuff N., Amend D.L., Tanabe J.L., Norman D., Maudsley A.A., Jagust W., Chui H.C., Fein G., Segal M.R., Weiner M.W. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy. Am. J. Neuroradiol. 2000, 21:621-630.
5. Chiang M.C., Barysheva M., Toga A.W., Medland S.E., Hansell N.K., James M.R., McMahon K.L., de Zubicaray G.I., Martin N.G., Wright M.J., Thompson P.M. BDNF gene effects on brain circuitry replicated in 455 twins. Neuroimage 2011, 55:448-454.
6. de Groot J.C., de Leeuw F.E., Oudkerk M., Hofman A., Jolles J., Breteler M.M. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch. Gen. Psychiatry 2000, 57:1071-1076.
7. Dinacci D., Tessitore A., Russo A., De Bonis M.L., Lavorgna L., Picconi O., Sacco R., Bonavita S., Gallo A., Servillo G., Marcuccio L., Comerci M., Galletti P., Alfano B., Tedeschi G. BDNF Val66Met polymorphism and brain volumes in multiple sclerosis. Neurol. Sci. 2011, 32:117-123.
8. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
9. Fernando M.S., Simpson J.E., Matthews F., Brayne C., Lewis C.E., Barber R., Kalaria R.N., Forster G., Esteves F., Wharton S.B., Shaw P.J., O'Brien J.T., Ince P.G. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006, 37:1391-1398.
10. Ferrer I., Krupinski J., Goutan E., Marti E., Ambrosio S., Arenas E. Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathol. 2001, 101:229-238.
11. Fiebach C.J., Friederici A.D., Smith E.E., Swinney D. Lateral inferotemporal cortex maintains conceptual-semantic representations in verbal working memory. J. Cogn. Neurosci. 2007, 19:2035-2049.
12. Firbank M.J., O'Brien J.T., Pakrasi S., Pantoni L., Simoni M., Erkinjuntti T., Wallin A., Wahlund L.O., van Straaten I., Inzitari D. White matter hyperintensities and depression - preliminary results from the LADIS study. Int. J. Geriatr. Psychiatry 2005, 20:674-679.
13. Gajewski P.D., Hengstler J.G., Golka K., Falkenstein M., Beste C. The Met-allele of the BDNF Val66Met polymorphism enhances task switching in elderly. Neurobiol. Aging 2011, 32(2327):e2319-e2327.
14. Gallinat J., Schubert F., Bruhl R., Hellweg R., Klar A.A., Kehrer C., Wirth C., Sander T., Lang U.E. Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. Neuroimage 2010, 49:767-771.
15. Gibson E., Gao F., Black S.E., Lobaugh N.J. Automatic segmentation of white matter hyperintensities in the elderly using FLAIR images at 3T. J. Magn. Reson. Imaging 2010, 31:1311-1322.
16. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 2003, 23:6690-6694.
17. Harris S.E., Fox H., Wright A.F., Hayward C., Starr J.M., Whalley L.J., Deary I.J. The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Mol. Psychiatry 2006, 11:505-513.
18. Houlihan L.M., Harris S.E., Luciano M., Gow A.J., Starr J.M., Visscher P.M., Deary I.J. Replication study of candidate genes for cognitive abilities: the Lothian Birth Cohort 1936. Genes Brain Behav. 2009, 8:238-247.
19. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982, 140:566-572.
20. Jiang R., Brummett B.H., Babyak M.A., Siegler I.C., Williams R.B. Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms. J. Psychiatr. Res. 2013, 47:233-239.
21. Jones K.R., Reichardt L.F. Molecular cloning of a human gene that is a member of the nerve growth factor family. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:8060-8064.
22. Kim K.W., MacFall J.R., Payne M.E. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol. Psychiatry 2008, 64:273-280.
23. Kohama S.G., Rosene D.L., Sherman L.S. Age-related changes in human and non-human primate white matter: from myelination disturbances to cognitive decline. Age (Dordr) 2011, 34:1093-1110.
24. Lang U.E., Hellweg R., Sander T., Gallinat J. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol. Psychiatry 2009, 14:120-122.
25. Lang U.E., Hellweg R., Seifert F., Schubert F., Gallinat J. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol. Psychiatry 2007, 62:530-535.
26. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H., Barde Y.A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989, 341:149-152.
27. Letty S., Lerner-Natoli M., Rondouin G. Differential impairments of spatial memory and social behavior in two models of limbic epilepsy. Epilepsia 1995, 36:973-982.
28. Liu H.C., Chou P., Lin K.N., Wang S.J., Fuh J.L., Lin H.C., Liu C.Y., Wu G.S., Larson E.B., White L.R., et al. Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen. Psychol. Med. 1994, 24:763-770.
29. Liu H.C., Teng E.L., Lin K.N., Chuang Y.Y., Wang P.N., Fuh J.L., Liu C.Y. Performance on the cognitive abilities screening instrument at different stages of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2002, 13:244-248.
30. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003, 19:1233-1239.
31. Mendez-Lopez M., Mendez M., Begega A., Arias J.L. Spatial short-term memory in rats: effects of learning trials on metabolic activity of limbic structures. Neurosci. Lett. 2010, 483:32-35.
32. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 2006, 7:818-827.
33. Miyajima F., Ollier W., Mayes A., Jackson A., Thacker N., Rabbitt P., Pendleton N., Horan M., Payton A. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behav. 2008, 7:411-417.
34. Nomura T., Honmou O., Harada K., Houkin K., Hamada H., Kocsis J.D. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 2005, 136:161-169.
35. Ota M., Nemoto K., Sato N., Yamashita F., Asada T. Relationship between white matter changes and cognition in healthy elders. Int. J. Geriatr. Psychiatry 2009, 24:1463-1469.
36. Pa J., Wilson S.M., Pickell H., Bellugi U., Hickok G. Neural organization of linguistic short-term memory is sensory modality-dependent: evidence from signed and spoken language. J. Cogn. Neurosci. 2008, 20:2198-2210.
37. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis: a review. Stroke 1997, 28:652-659.
38. Rango M., Spagnoli D., Tomei G., Bamonti F., Scarlato G., Zetta L. Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study. Magn. Reson. Med. 1995, 33:595-600.
39. Ruchkin D.S., Berndt R.S., Johnson R.J.R., Grafman J., Ritter W., Canoune H.L. Lexical contributions to retention of verbal information in working memory: event-related brain potential evidence. J. Mem. Lang. 1999, 41:345-364.
40. Sachdev P., Chen X., Wen W. White matter hyperintensities in mid-adult life. Curr. Opin. Psychiatry 2008, 21:268-274.
41. Sachdev P., Wen W., Chen X., Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology 2007, 68:214-222.
42. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
43. Smith D.E., Rapp P.R., McKay H.M., Roberts J.A., Tuszynski M.H. Memory impairment in aged primates is associated with focal death of cortical neurons and atrophy of subcortical neurons. J. Neurosci. 2004, 24:4373-4381.
44. Smith E.E., Egorova S., Blacker D., Killiany R.J., Muzikansky A., Dickerson B.C., Tanzi R.E., Albert M.S., Greenberg S.M., Guttmann C.R. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch. Neurol. 2008, 65:94-100.
45. Smith E.E., Salat D.H., Jeng J., McCreary C.R., Fischl B., Schmahmann J.D., Dickerson B.C., Viswanathan A., Albert M.S., Blacker D., Greenberg S.M. Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology 2011, 76:1492-1499.
46. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
47. Swartz B.E., Halgren E., Fuster J., Mandelkern M. An 18FDG-PET study of cortical activation during a short-term visual memory task in humans. Neuroreport 1994, 5:925-928.
48. Taylor W.D., Zuchner S., McQuoid D.R., Payne M.E., MacFall J.R., Steffens D.C., Speer M.C., Krishnan K.R. The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. Am. J. Geriatr. Psychiatry 2008, 16:263-271.
49. Tognoni G., Ceravolo R., Nucciarone B., Bianchi F., Dell'Agnello G., Ghicopulos I., Siciliano G., Murri L. From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy. Acta Neurol. Scand. 2005, 112:65-71.
50. Tost H., Alam T., Geramita M., Rebsch C., Kolachana B., Dickinson D., Verchinski B.A., Lemaitre H., Barnett A.S., Trampush J.W., Weinberger D.R., Marenco S. Effects of the BDNF Val66Met polymorphism on white matter microstructure in healthy adults. Neuropsychopharmacology 2013, 38:525-532.
51. Ventriglia M., Bocchio Chiavetto L., Benussi L., Binetti G., Zanetti O., Riva M.A., Gennarelli M. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol. Psychiatry 2002, 7:136-137.
52. Voineskos A.N., Lerch J.P., Felsky D., Shaikh S., Rajji T.K., Miranda D., Lobaugh N.J., Mulsant B.H., Pollock B.G., Kennedy J.L. The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch. Gen. Psychiatry 2011, 68:198-206.
53. Yamada K., Mizuno M., Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 2002, 70:735-744.
54. Zivadinov R., Weinstock-Guttman B., Benedict R., Tamano-Blanco M., Hussein S., Abdelrahman N., Durfee J., Ramanathan M. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum. Mol. Genet. 2007, 16:2659-2668.
55. Zlokovic B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005, 28:202-208.